Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-07-11

FDA Approved: MUCUS RELIEF EXTENDED RELEASE — Original Application (Care One (American Sales Company))

View source ↗

Summary

FDA approved the original application for MUCUS RELIEF EXTENDED RELEASE (guaifenesin) from Care One (American Sales Company).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MUCUS RELIEF EXTENDED RELEASE (guaifenesin)

Snippet

ORIG AP for MUCUS RELIEF EXTENDED RELEASE (GUAIFENESIN)